These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 25651718

  • 21. Podocyte number predicts progression of proteinuria in IgA nephropathy.
    Xu L, Yang HC, Hao CM, Lin ST, Gu Y, Ma J.
    Mod Pathol; 2010 Sep; 23(9):1241-50. PubMed ID: 20495534
    [Abstract] [Full Text] [Related]

  • 22. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
    Bellur SS, Lepeytre F, Vorobyeva O, Troyanov S, Cook HT, Roberts IS, International IgA Nephropathy Working Group.
    Kidney Int; 2017 Jan; 91(1):235-243. PubMed ID: 27914703
    [Abstract] [Full Text] [Related]

  • 23. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin.
    Hara M, Yamagata K, Tomino Y, Saito A, Hirayama Y, Ogasawara S, Kurosawa H, Sekine S, Yan K.
    Diabetologia; 2012 Nov; 55(11):2913-9. PubMed ID: 22854890
    [Abstract] [Full Text] [Related]

  • 24. Correlation of proteinuria with podocyte foot process effacement in IgA nephropathy: an ultrastructural study.
    Tewari R, Nada R, Rayat CS, Boruah D, Dudeja P, Joshi K, Sakhuja V.
    Ultrastruct Pathol; 2015 Apr; 39(2):147-51. PubMed ID: 25268180
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
    Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E.
    Nefrologia; 2017 Apr; 37(5):531-538. PubMed ID: 28946966
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy.
    Rocchetti MT, Papale M, d'Apollo AM, Suriano IV, Di Palma AM, Vocino G, Montemurno E, Varraso L, Grandaliano G, Di Paolo S, Gesualdo L.
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1115-25. PubMed ID: 23599406
    [Abstract] [Full Text] [Related]

  • 31. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity.
    Li G, Wu W, Zhang X, Huang Y, Wen Y, Li X, Gao R.
    BMC Nephrol; 2018 Nov 14; 19(1):326. PubMed ID: 30428849
    [Abstract] [Full Text] [Related]

  • 32. Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study.
    Mizdrak M, Vukojević K, Filipović N, Čapkun V, Benzon B, Durdov MG.
    Diagn Pathol; 2018 Nov 20; 13(1):90. PubMed ID: 30458823
    [Abstract] [Full Text] [Related]

  • 33. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.
    Clin Nephrol; 2003 Nov 20; 60(5):318-26. PubMed ID: 14640237
    [Abstract] [Full Text] [Related]

  • 34. The urine albumin-to-creatinine ratio is a reliable indicator for evaluating complications of chronic kidney disease and progression in IgA nephropathy in China.
    Huan L, Yuezhong L, Chao W, HaiTao T.
    Clinics (Sao Paulo); 2016 May 20; 71(5):243-50. PubMed ID: 27276392
    [Abstract] [Full Text] [Related]

  • 35. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.
    Nishiyama A, Konishi Y, Ohashi N, Morikawa T, Urushihara M, Maeda I, Hamada M, Kishida M, Hitomi H, Shirahashi N, Kobori H, Imanishi M.
    Nephrol Dial Transplant; 2011 Jan 20; 26(1):170-7. PubMed ID: 20615910
    [Abstract] [Full Text] [Related]

  • 36. Urine synaptopodin excretion is an important marker of glomerular disease progression.
    Kwon SK, Kim SJ, Kim HY.
    Korean J Intern Med; 2016 Sep 20; 31(5):938-43. PubMed ID: 27604800
    [Abstract] [Full Text] [Related]

  • 37. Collagen IV and Podocyte-Related Gene Variants in Patients with Concurrent IgA Nephropathy and Thin Basement Membrane Nephropathy.
    Xu H, Yu X, Li Y, Huang Z, Zhang L, Min Q, Bi J, Li Z, Liu L, Liang Y, Xu Z, Sun H, Yang S, Shao M.
    Nephron; 2023 Sep 20; 147(5):301-310. PubMed ID: 36349777
    [Abstract] [Full Text] [Related]

  • 38. Mesangial medium from IgA nephropathy patients induces podocyte epithelial-to-mesenchymal transition through activation of the phosphatidyl inositol-3-kinase/Akt signaling pathway.
    Wang C, Liu X, Ke Z, Tang Y, Li CC, Li CM, Ye Z, Zhang J, Lou T.
    Cell Physiol Biochem; 2012 Sep 20; 29(5-6):743-52. PubMed ID: 22613975
    [Abstract] [Full Text] [Related]

  • 39. TWEAK/Fn14 system and crescent formation in IgA nephropathy.
    Sasaki Y, Shimizu Y, Suzuki Y, Horikoshi S, Tomino Y.
    BMC Nephrol; 2015 Mar 14; 16():27. PubMed ID: 25885587
    [Abstract] [Full Text] [Related]

  • 40. Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
    Branten AJ, Klasen IS, Wetzels JF.
    Clin Nephrol; 2002 Oct 14; 58(4):267-74. PubMed ID: 12400841
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.